EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma.

The purpose of this document is to assist physicians, patients, health-care providers and health-policy makers from Europe and worldwide in the decision-making process according to evidence-based data. Users of these guidelines should be aware that the recommenda- tions are intended to guide clinical practice in circumstances where all possible resources and therapies are available. Thus, they should adapt the recommendations to their local regulations and/or team capacities, infra- structure and cost–benefit strategies. Finally, this docu- ment sets out some recommendations that should be instrumental in advancing the research and knowledge of this disease and ultimately contribute to improve patient care.